Ratings by Stifel (Alex Thompson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2026 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2026 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 2/27/2026 | Aclaris Therapeutis | ACRS | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2026 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 2/26/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Equillium | EQ | New Coverage | Buy (N/A) |
1.85 (1.77) |
-4.32% | Details | |
| 2/24/2026 | Palisade Bio Inc. | PALI | New Coverage | Buy (N/A) |
1.61 (1.63) |
1.24% | Details | |
| 2/24/2026 | Alumis Inc | ALMS | New Coverage | Buy (N/A) |
27.65 (26.90) |
-2.71% | Details | |
| 2/23/2026 | Moonlake Immunotherapeutics | MLTX | Maintain | Hold (N/A) |
|
Details | ||
| 2/12/2026 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2026 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2026 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | Travere Therapeutics | TVTX | Maintain | Hold (Hold) |
|
Details | ||
| 1/12/2026 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 1/9/2026 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 1/8/2026 | Ventyx Biosciences Inc | VTYX | Maintain | Hold (Hold) |
|
Details | ||
| 1/6/2026 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2025 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 11/14/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (Buy) |
|
Details | ||
| 11/11/2025 | Celldex Therapeutics | CLDX | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2025 | Ventyx Biosciences Inc | VTYX | Maintain | Hold (N/A) |
|
Details | ||
| 11/5/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 10/30/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | Moonlake Immunotherapeutics | MLTX | Downgrade | Hold (Buy) |
56.38 (18.15) |
-67.81% | Details | |
| 9/26/2025 | Crinetics | CRNX | Maintain | Buy (Buy) |
|
Details | ||
| 9/18/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2025 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 8/20/2025 | Celldex Therapeutics | CLDX | Maintain | Buy (Buy) |
|
Details | ||
| 8/11/2025 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 8/8/2025 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2025 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2025 | Avalo Therapeutics Inc. | AVTX | Maintain | Buy (Buy) |
|
Details | ||
| 7/21/2025 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (Buy) |
|
Details | ||
| 6/17/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (Buy) |
|
Details | ||
| 6/4/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2025 | Kymera Therapeutics | KYMR | New Coverage | Buy (N/A) |
30.25 (83.49) |
176% | Details | |
| 5/16/2025 | Travere Therapeutics | TVTX | Maintain | Hold (Hold) |
|
Details | ||
| 5/15/2025 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (Buy) |
|
Details | ||
| 5/6/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2025 | Jade Biosciences | JBIO | New Coverage | Buy (N/A) |
10.00 (14.05) |
40.5% | Details | |
| 5/2/2025 | Travere Therapeutics | TVTX | Maintain | Hold (Hold) |
|
Details | ||
| 4/11/2025 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2025 | Third Harmonic Bio | THRD | Downgrade | Hold (Buy) |
3.53 (5.38) |
52.41% | Details | |
| 3/25/2025 | Crinetics | CRNX | New Coverage | Buy (N/A) |
34.42 (38.23) |
11.07% | Details | |
| 3/25/2025 | Avalo Therapeutics Inc. | AVTX | New Coverage | Buy (N/A) |
7.66 (17.31) |
125.98% | Details | |
| 3/20/2025 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2025 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Pliant Therapeutics | PLRX | Downgrade | Hold (Buy) |
3.44 (1.33) |
-61.34% | Details | |
| 2/28/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Aclaris Therapeutis | ACRS | Maintain | Hold (N/A) |
|
Details | ||
| 2/13/2025 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2024 | Aclaris Therapeutis | ACRS | Maintain | Hold (N/A) |
|
Details | ||
| 11/15/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2024 | Rapt Therapeutics | RAPT | Downgrade | Hold (Buy) |
1.75 (58.02) |
3215.43% | Details | |
| 11/12/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (Buy) |
|
Details | ||
| 11/12/2024 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Pliant Therapeutics | PLRX | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2024 | Third Harmonic Bio | THRD | Maintain | Buy (Buy) |
|
Details | ||
| 11/6/2024 | Aclaris Therapeutis | ACRS | Maintain | Hold (N/A) |
|
Details | ||
| 10/31/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2024 | Oruka Therapeutics | ORKA | New Coverage | Buy (N/A) |
28.46 (32.97) |
15.85% | Details | |
| 10/9/2024 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 9/25/2024 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | Morphic Therapeutic | MORF | Maintain | Hold (N/A) |
|
Details | ||
| 6/24/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2024 | Celldex Therapeutics | CLDX | New Coverage | Buy (N/A) |
34.67 (29.43) |
-15.11% | Details | |
| 6/18/2024 | Third Harmonic Bio | THRD | New Coverage | Buy (N/A) |
13.33 (3.53) |
-73.52% | Details | |
| 5/31/2024 | Ascendis Pharma | ASND | New Coverage | Buy (N/A) |
132.51 (240.65) |
81.61% | Details | |
| 5/14/2024 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2024 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | AnaptysBio | ANAB | New Coverage | Hold (N/A) |
24.10 (55.41) |
129.92% | Details | |
| 2/20/2024 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2024 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
23.36 (65.20) |
179.11% | Details | |
| 1/12/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Ventyx Biosciences Inc | VTYX | Maintain | Hold (N/A) |
|
Details | ||
| 12/18/2023 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 12/18/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Aclaris Therapeutis | ACRS | Maintain | Hold (N/A) |
|
Details | ||
| 11/13/2023 | Aclaris Therapeutis | ACRS | Downgrade | Hold (Buy) |
4.76 (3.06) |
-35.71% | Details | |
| 11/10/2023 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Ventyx Biosciences Inc | VTYX | Downgrade | Hold (Buy) |
14.09 (14.00) |
-0.64% | Details | |
| 11/2/2023 | Moonlake Immunotherapeutics | MLTX | New Coverage | Buy (N/A) |
51.81 (56.38) |
8.82% | Details | |
| 10/23/2023 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2023 | Morphic Therapeutic | MORF | Maintain | Hold (N/A) |
|
Details | ||
| 9/26/2023 | Immunovant | IMVT | Maintain | Buy (Buy) |
|
Details | ||
| 9/25/2023 | Morphic Therapeutic | MORF | Maintain | Hold (N/A) |
|
Details | ||
| 9/21/2023 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 9/13/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2023 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Morphic Therapeutic | MORF | Downgrade | Hold (Buy) |
56.41 (56.99) |
1.03% | Details | |
| 8/9/2023 | Rapt Therapeutics | RAPT | New Coverage | Buy (N/A) |
22.01 (1.75) |
-92.05% | Details | |
| 8/8/2023 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
20.70 (73.05) |
252.9% | Details | |
| 8/4/2023 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 7/25/2023 | Aeglea Biotherapeutics | AGLE | New Coverage | Buy (N/A) |
0.59 (12.01) |
1935.59% | Details | |
| 7/18/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2023 | DICE Therapeutics | DICE | Downgrade | Hold (Buy) |
33.85 (47.55) |
40.47% | Details | |
| 6/13/2023 | Chinook Therapeutics | KDNY | Downgrade | Hold (Buy) |
37.98 (40.39) |
6.35% | Details | |
| 5/5/2023 | Travere Therapeutics | TVTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/30/2023 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
25.04 (28.34) |
13.18% | Details | |
| 3/30/2023 | Immunovant | IMVT | New Coverage | Buy (N/A) |
15.50 (26.66) |
72% | Details | |
| 3/17/2023 | Ventyx Biosciences Inc | VTYX | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2023 | Morphic Therapeutic | MORF | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2023 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2022 | Chinook Therapeutics | KDNY | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Travere Therapeutics | TVTX | New Coverage | Hold (N/A) |
18.90 (27.24) |
44.13% | Details | |
| 12/13/2022 | Aclaris Therapeutis | ACRS | New Coverage | Buy (N/A) |
15.59 (3.06) |
-80.37% | Details | |
| 12/13/2022 | Pliant Therapeutics | PLRX | New Coverage | Buy (N/A) |
18.72 (3.44) |
-81.62% | Details | |
| 10/11/2022 | DICE Therapeutics | DICE | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2022 | Morphic Therapeutic | MORF | New Coverage | Buy (N/A) |
28.33 (56.99) |
101.16% | Details | |
| 9/7/2022 | DICE Therapeutics | DICE | New Coverage | Buy (N/A) |
18.02 (33.85) |
87.85% | Details | |
| 9/7/2022 | Ventyx Biosciences Inc | VTYX | New Coverage | Buy (N/A) |
21.80 (14.00) |
-35.78% | Details | |
| 6/28/2022 | Chinook Therapeutics | KDNY | New Coverage | Buy (N/A) |
18.05 (40.39) |
123.77% | Details | |
| 6/28/0004 | Agile Therapeutics | AGRX | New Coverage | Buy (N/A) |
1.15 (1.51) |
31.3% | Details |
